Cargando…

Cytosine Arabinoside and Mitoxantrone Followed by Second Allogeneic Transplant for the Treatment of Children With Refractory Juvenile Myelomonocytic Leukemia

Hematopoietic stem cell transplantation (HSCT) remains the only curative option for most patients with juvenile myelomonocytic leukemia (JMML). However, persistent disease and relapse rates after transplant range from 26% to 58%. We report the successful use of second HSCT after preparation with mit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Sachit A., Coulter, Don W., Grovas, Alfred C., Gordon, Bruce G., Harper, James L., Warkentin, Phyllis I., Wisecarver, James L., Sanger, Warren G., Coccia, Peter F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048652/ https://www.ncbi.nlm.nih.gov/pubmed/24322499 http://dx.doi.org/10.1097/MPH.0000000000000077

Ejemplares similares

A radioimmunoassay for cytosine arabinoside.
por: Piall, E. M., et al.
Publicado: (1979)

Enhancement of the Cytotoxicity of Cytosine Arabinoside by Interleukin‐3
por: Tanaka, Masao
Publicado: (1992)

High-dose cytosine arabinoside (Ara-C) in colorectal cancer.
por: Kanojia, M., et al.
Publicado: (1983)

Synergistic killing of human leukaemic lymphoblasts by glucocorticoids and cytosine arabinoside.
por: Gledhill, R. M., et al.
Publicado: (1983)

Toxicity associated with high-dose cytosine arabinoside and total body irradiation as conditioning for allogeneic bone marrow transplantation
por: Kumar, M, et al.
Publicado: (1997)

Sensitivity of normal and acute myelogenous leukaemia marrow cells to inhibition by cytosine arabinoside.
por: Potter, C. G., et al.
Publicado: (1980)

High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia.
por: Rohatiner, A. Z., et al.
Publicado: (1990)

Clinical trial of low dose cytosine arabinoside in the treatment of acute promyelocytic leukemia.
por: Sung, K. W., et al.
Publicado: (1997)

Effect of cytosine arabinoside on cerebellar neurofilaments during development: A sexual dimorphism
por: Koros, Christos, et al.
Publicado: (2014)

Combination chemotherapy for choroidal melanoma: ex vivo sensitivity to treosulfan with gemcitabine or Cytosine arabinoside
por: Neale, M H, et al.
Publicado: (1999)

Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia
por: Tse, Eric, et al.
Publicado: (2011)

Evaluating the use of cytosine arabinoside for treatment for recurrent canine steroid-responsive meningitis-arteritis
por: Günther, Christian, et al.
Publicado: (2020)

Interaction of 6-thioguanine and cytosine arabinoside in cultured cells from patients with acute myeloid leukaemia.
por: Robins, A. B.
Publicado: (1978)

Aprepitant Sensitizes Acute Myeloid Leukemia Cells to the Cytotoxic Effects of Cytosine Arabinoside in vitro and in vivo
por: Wu, Hongzhang, et al.
Publicado: (2020)

Micronucleated Erythrocytes in Peripheral Blood from Neonate Rats Exposed by Breastfeeding to Cyclophosphamide, Colchicine, or Cytosine-Arabinoside
por: Gómez-Meda, Belinda C., et al.
Publicado: (2016)

Signature-Based Small Molecule Screening Identifies Cytosine Arabinoside as an EWS/FLI Modulator in Ewing Sarcoma
por: Stegmaier, Kimberly, et al.
Publicado: (2007)

Proceedings: Effects of daunomycin, bleomycin, cytosine arabinoside, acronycine and ionizing radiation on the cell cycle in vitro and in vivo.
por: Linden, W. A., et al.
Publicado: (1975)

High-dose cytosine arabinoside plus etoposide as initial treatment for acute myeloid leukaemia: a single centre study.
por: Parikh, P., et al.
Publicado: (1990)

The diagnostic dilemma of idiopathic intracranial hypertension in a child with acute lymphoblastic leukemia: COVID-19 or cytosine arabinoside?
por: Rakez, Rim, et al.
Publicado: (2022)

Human tumour xenografts established and serially transplanted in mice immunologically deprived by thymectomy, cytosine arabinoside and whole-body irradiation.
por: Selby, P. J., et al.
Publicado: (1980)

Effects of cytosine arabinoside on differential gene expression in embryonic neural retina. II. Immunochemical studies on the accumulation of glutamine synthetase
Publicado: (1977)

Preparation and in vitro antitumor effects of cytosine arabinoside-loaded genipin-poly-l-glutamic acid-modified bacterial magnetosomes
por: Liu, Yuan-Gang, et al.
Publicado: (2015)

Construction of a Novel Magnetic Targeting Anti-Tumor Drug Delivery System: Cytosine Arabinoside-Loaded Bacterial Magnetosome
por: Deng, Qiongjia, et al.
Publicado: (2013)

Allogeneic bone marrow transplantation for juvenile myelomonocytic leukemia: a single center experience of 23 patients
por: Korthof, E T, et al.
Publicado: (2005)

EFFECTS OF CYTOSINE ARABINOSIDE ON DIFFERENTIAL GENE EXPRESSION IN EMBRYONIC NEURAL RETINA : I. Accumulation of Glutamine Synthetase with Suppression of Macromolecular Synthesis
por: Jones, R. E., et al.
Publicado: (1974)

Prevention of High-Dose Cytosine Arabinoside-Induced Acute Pericarditis with Preemptive Dexamethasone Administration: A Case Report and Literature Review
por: Owattanapanich, Weerapat, et al.
Publicado: (2018)

Low frequency of pre-treatment and post-treatment haematological abnormalities in dogs with non-infectious meningoencephalitis treated with cytosine arabinoside and prednisolone
por: Keegan, Sarah, et al.
Publicado: (2019)

Intravesical mitomycin C (MMC) and MMC + cytosine arabinoside for non‐muscle‐invasive bladder cancer: a randomised clinical trial
por: Miyata, Yasuyoshi, et al.
Publicado: (2021)

The Genomic Landscape of Juvenile Myelomonocytic Leukemia
por: Stieglitz, Elliot, et al.
Publicado: (2015)

Current Treatment of Juvenile Myelomonocytic Leukemia
por: Mayerhofer, Christina, et al.
Publicado: (2021)

The combination of methotrexate and cytosine arabinoside in newly diagnosed adult Langerhans cell histiocytosis: a prospective phase II interventional clinical trial
por: Han, Xiao, et al.
Publicado: (2020)

Molecular Targets for the Treatment of Juvenile Myelomonocytic Leukemia
por: Liu, Xiaoling, et al.
Publicado: (2012)

Genomic and Epigenomic Landscape of Juvenile Myelomonocytic Leukemia
por: Fiñana, Claudia, et al.
Publicado: (2022)

Assessment of drug sensitivity of human leukaemic myeloblasts. II. The toxic effects of cytosine arabinoside on 125IUdR-labelled human leukaemic myeloblasts in mice.
por: Sonis, S. T., et al.
Publicado: (1977)

Enhancement of Cytosine Arabinoside Cytotoxicity by Granulocyte/Macrophage Colony‐stimulating Factor and Granulocyte Colony‐stimulating Factor in a Human Myeloblastic Leukemia Cell Line
por: Takauji, Rumiko, et al.
Publicado: (1993)

Iron Oxide Nanoparticles Combined with Cytosine Arabinoside Show Anti-Leukemia Stem Cell Effects on Acute Myeloid Leukemia by Regulating Reactive Oxygen Species
por: Dou, Jun, et al.
Publicado: (2021)

Novel splicing-factor mutations in juvenile myelomonocytic leukemia
por: Takita, J, et al.
Publicado: (2012)

Molecular and phenotypic diversity of CBLmutated juvenile myelomonocytic leukemia
por: Hecht, Anna, et al.
Publicado: (2020)

P1072: NATURAL HISTORY OF JUVENILE MYELOMONOCYTIC LEUKEMIA
por: Yang, W., et al.
Publicado: (2022)

Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemia
por: Louka, Eleni, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_latghm5jer7smm69mis0tvkav8